In Vitro antibacterial activity of panduratin a against enterococci clinical isolates

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 9, 2010, Pages 1489-1493

  Rukayadi, Yaya ^a,b   Han, Sunghwa ^a   Yong, Dongeun ^a   Hwang, Jae Kwan ^a  

^a Yonsei University   (South Korea)

^b BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

Antibacterial activity; Enterococci; Panduratin A

Indexed keywords

AMPICILLIN; CHALCONE DERIVATIVE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; PANDURATIN A; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; BOESENBERGIA ROTUNDA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GROWTH INHIBITION; MEDICINAL PLANT; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; RHIZOME;

ANTI-BACTERIAL AGENTS; CHALCONES; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 77957555872     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1489     Document Type: Article

References (23)

1. Biedenbach D. J., Moet G. J., Jones R. N., Diagn. Microbiol. Infect. Dis., 50, 59-69 (2004).
2. Murray B. E., N. Engl. J. Med., 342, 710-721 (2000).
3. Lai K. K., Arch. Intern. Med., 156, 2579-2584 (1996).
4. Morrison A. J. Jr., Wenzel R. P., Arch. Intern. Med., 146, 1549-1551 (1986).
5. Wong A. H. M., Wenzel R. P., Edmond M. B., Am. J. Infect. Control, 28, 277-281 (2000).
6. Yong D., Yum J. H., Lee K., Chong Y., Choi S. H., Rhee J. K., Antimicrob. Agents Chemother., 48, 352-357 (2004).
7. Zurenko G. E., Yagi B. H., Schaadt R. D., Allison J. W., Kilburn J. O., Glickman S. E., Hutchinson D. K., Barbachyn M. R., Brickner S. J., Antimicrob. Agents Chemother., 40, 839-845 (1996).
8. Sahlstrom L., Rehbinder V., Albihn A., Aspan A., Bengtsson B., Acta Vet. Scand., 51, 24-33 (2009).
9. Liao M., Ruddock P. S., Rizvi A. S., Hall S. H., French F. S., Dillon J. R., J. Antimicrob. Chemother., 56, 957-961 (2005).
10. Emori T. G., Gaynes R. P., Clin. Microbiol. Rev., 6, 428-442 (1993).
11. Machado T. B., Pinto A. V., Pinto M. C., Leal I. C., Silva M. G., Amaral A. C., Kuster R. M., Netto-dosSantos K. R., Int. J. Antimicrob. Agents, 21, 279-284 (2003).
12. Hwang J. K., Shim J. S., Chung J. Y., Fitoterapia, 75, 596-598 (2004).
13. Park K. M., Choo J. H., Sohn J. H., Lee S. H., Hwang J. K., Food Sci. Biotechnol. 14, 286-289 (2005).
14. Song M. S., Shim J. S., Gwon S. H., Lee C. W., Kim H. S., Hwang J. K., Food Sci. Biotechnol., 17, 1357-1360 (2008).
15. Rukayadi Y., Lee K. H., Hwang J. K., J. Oral Sci., 51, 87-95 (2009).
16. Rukayadi Y., Lee K., Han S., Yong D., Hwang J. K., Antimicrob. Agents Chemother., 53, 4529-4532 (2009).
17. Clinical and Laboratory Standards Institute (CLSI), "Document M7- A6, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Guideline," Wayne, PA, 2003.
18. Lorian V., "Antibiotics in Laboratory Medicine," 5th ed., Lippincott Williams and Wilkins, London, 2005.
19. French G. L., J. Antimicrob. Chemother., 58, 1107-1117 (2006).
20. Pankey G. A., Ashcraft D. S., Diagnos. Microbiol. Infect. Dis., 64, 300-304 (2009).
21. Sandoe J. A. T., Wysome J., West A. P., Heritage J., Wilcox M. H., J. Antimicrob. Chemother., 57, 767-770 (2006).
22. Shanks R. M. Q., Sargent J. L., Martinez R. M., Graber M. L., O'Toole G. A., Nephrol. Dial. Transplant., 21, 2247-2255 (2006).
23. Shanks R. M. Q., Donegan N. P., Graber M. L., Buckingham S. R., Zegans M. E., Cheung A. L., O'Toole G. A., Infect. Immun., 73, 4596-4606 (2005).